BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 77.5%

Neg 0% Neu 77.5% Pos 0%

BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.

Comments

No comments yet. Be the first!